Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 8:12:100133.
doi: 10.1016/j.tcsw.2024.100133. eCollection 2024 Dec.

Combatting biofilm-mediated infections in clinical settings by targeting quorum sensing

Affiliations
Review

Combatting biofilm-mediated infections in clinical settings by targeting quorum sensing

Arindam Mitra. Cell Surf. .

Abstract

Biofilm-associated infections constitute a significant challenge in managing infectious diseases due to their high resistance to antibiotics and host immune responses. Biofilms are responsible for various infections, including urinary tract infections, cystic fibrosis, dental plaque, bone infections, and chronic wounds. Quorum sensing (QS) is a process of cell-to-cell communication that bacteria use to coordinate gene expression in response to cell density, which is crucial for biofilm formation and maintenance.. Its disruption has been proposed as a potential strategy to prevent or treat biofilm-associated infections leading to improved treatment outcomes for infectious diseases. This review article aims to provide a comprehensive overview of the literature on QS-mediated disruption of biofilms for treating infectious diseases. It will discuss the mechanisms of QS disruption and the various approaches that have been developed to disrupt QS in reference to multiple clinical pathogens. In particular, numerous studies have demonstrated the efficacy of QS disruption in reducing biofilm formation in various pathogens, including Pseudomonas aeruginosa and Staphylococcus aureus. Finally, the review will discuss the challenges and future directions for developing QS disruption as a clinical therapy for biofilm-associated infections. This includes the development of effective delivery systems and the identification of suitable targets for QS disruption. Overall, the literature suggests that QS disruption is a promising alternative to traditional antibiotic treatment for biofilm-associated infections and warrants further investigation.

Keywords: AMR; Antibiofilm strategy; Antibiotic resistance; Biofilms; Infectious diseases; QSI (Quorum sensing inhibition).

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Key biofilm characteristics that enhance antimicrobial resistance mechanisms.
Fig. 2
Fig. 2
Role of quorum sensing in the regulation of biofilm formation, maturation, and dissemination.
Fig. 3
Fig. 3
Quorum sensing disruption as a strategy to interfere with biofilm-associated infections.

Similar articles

Cited by

References

    1. Amer M.A., Ramadan M.A., Attia A.S., Wasfi R. Silicone Foley catheters impregnated with microbial indole derivatives inhibit crystalline biofilm formation by Proteus mirabilis. Front. Cell. Infect. Microbiol. 2022;12 - PMC - PubMed
    1. Anbazhagan D., Mansor M., Yan G.O., Md Yusof M.Y., Hassan H., et al. Detection of quorum sensing signal molecules and identification of an autoinducer synthase gene among biofilm forming clinical isolates of Acinetobacter spp. PLoS One. 2012;7(7) - PMC - PubMed
    1. Antimicrobial Resistance C Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. - PMC - PubMed
    1. Arendse M., Khan S., Wani M.Y., Aqlan F.M., Al-Bogami A.S., Ahmad A. Quorum sensing and biofilm disrupting potential of imidazole derivatives in Chromobacterium violaceum using antimicrobial and drug discovery approaches. Braz. J. Microbiol. 2022;53(2):565–582. - PMC - PubMed
    1. Bai Y., Wang W., Shi M., Wei X., Zhou X., Li B., Zhang J. Novel antibiofilm inhibitor Ginkgetin as an antibacterial synergist against Escherichia coli. Int. J. Mol. Sci. 2022;23(15) - PMC - PubMed

LinkOut - more resources